BUSINESS BRIEF
A cold chain transportation company focused on pharmaceutical logistics is seeking a strategic investor / sell-side transaction to accelerate expansion and scale operations.
Key Investment Highlights:
- Established client base across multiple industries
- Premium pharmaceutical client base
- Strong historical revenue growth
- Owned vehicle fleet
- Pan-India operations
- Diversified customer base with no significant client concentration
- Strong return on capital employed
- Strong return on equity
- Established operating history
- Low debt
Products & Services
Cold chain transportation services including temperature-controlled pharma logistics, full truck load (FTL) transportation, primary and secondary distribution, intercity and regional logistics, and pan-India refrigerated fleet operations.
Proposal
Industry
Transportation/Logistics
Sub Industry
Truck Transportation and Services (Road freight services) & Logistics (Cold Chain Logistics)
Nature of Business
B2B, B2G
Sector
Services
Reason for sell-off
Strategic Realignment or Pursuing New Opportunities
Location
India
Region
Western
Open For Dilution
100 % (Complete Buyout)
Top Customer
Deal Size
INR 120 - 125 Cr
Justification
Strong growth trajectory with revenue crossing ₹75 Cr in FY26, supported by premium pharmaceutical clientele ensuring stable and recurring business. Additionally, 30% revenue from hired vehicles reflects an asset-light, scalable model, strengthening the company’s valuation potential.
Business Operation Information
Financial Information |
2026 (in INR Cr) | 2025 (in INR Cr) | 2024 (in INR Cr) |
|---|---|---|---|
Sales |
N.D | 57.5 | 43.9 |
EBITDA |
N.D | ||
PAT |
N.D |
